Cost-effectiveness of a self-management intervention for patients with Chronic Obstructive Pulmonary Disease and common comorbidities

The COPE-III study introduced a self-management intervention incorporating tailored action plans for COPD patients with prevalent comorbidities. Before implementation, a cost-effectiveness analysis is needed for healthcare decision-makers to allocate resources wisely and prioritize the intervention based on its benefits and costs.